Navamedic ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Navamedic ASA's CEO Steps Down
Navamedic ASA announced that the Company's Chief Executive Officer (CEO) has decided to step down. He will remain with Navamedic as a strategic advisor. The Board of Directors has appointed Mr. Hakan Josephsson as interim CEO of Navamedic until a permanent Chief Executive takes office. Mr. Josephsson is Managing Director of the Swedish subsidiary Navamedic AB and Head of the group's Nordic operations.
Latest Key Developments in Pharmaceuticals
- FDA approves Gilead Sciences Inc's Sovaldi the treatment of Chronic Hepatitis C
- Auxilium Pharmaceuticals Inc's drug to treat bent penis condition gets U.S. approval - Reuters
- Innovus Pharmaceuticals Inc receives product license approval of EjectDelay for premature ejaculation from Health Canada
- GSK and Theravance announce positive results from pivotal phase iii study for fluticasone furoate/vilanterol in asthma
- Share this
- Digg this